Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BIA 5-1058

NCT03708146 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

157

Enrollment

INDUSTRY

Sponsor class

Conditions

Cardiovascular Disease+Pulmonary Disease
Pulmonary Arterial Hypertension

Interventions

DRUG: BIA 5-1058
DRUG: Placebo

Sponsor

Bial - Portela C S.A.